Tus Pharmaceutical Group Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.004x

Tus Pharmaceutical Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Tus Pharmaceutical Group Co Ltd (000590) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥2.24 Million ≈ $327.43K USD) by net assets (CN¥585.85 Million ≈ $85.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tus Pharmaceutical Group Co Ltd (1998–2025)

Cash flow conversion efficiency of Tus Pharmaceutical Group Co Ltd from 1998 to 2025. This chart illustrates how Tus Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Tus Pharmaceutical Group Co Ltd for real-time trading data and today's change.

Tus Pharmaceutical Group Co Ltd Cash Flow Conversion Ratio Explained

Tus Pharmaceutical Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tus Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tus Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Also see 000590 market cap overview for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Rapac Communication & Infrastructure Ltd TA:RPAC	-0.017x
Leonteq AG SW:LEON	0.774x
Imperial Brands PLC LSE:IMB	-0.086x
Hedef Holdings AS IS:HEDEF	0.025x
Pengana Private Equity Trust AU:PE1	0.006x
Aurion Resources Ltd V:AU	-0.009x
Sampo Corp TW:1604	0.019x
Instone Real Estate Group AG XETRA:INS	-0.012x

Annual Cash Flow Conversion Efficiency for Tus Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Tus Pharmaceutical Group Co Ltd from 1998 to 2025. Review free cash flow generation of Tus Pharmaceutical Group Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥549.49 Million ≈ $80.41 Million	CN¥28.96 Million ≈ $4.24 Million	0.053x	+82.22%
2024-12-31	CN¥601.23 Million ≈ $87.98 Million	CN¥17.39 Million ≈ $2.54 Million	0.029x	+174.17%
2023-12-31	CN¥728.20 Million ≈ $106.56 Million	CN¥-28.39 Million ≈ $-4.16 Million	-0.039x	-150.29%
2022-12-31	CN¥702.49 Million ≈ $102.80 Million	CN¥54.47 Million ≈ $7.97 Million	0.078x	+109.99%
2021-12-31	CN¥682.32 Million ≈ $99.85 Million	CN¥25.20 Million ≈ $3.69 Million	0.037x	-53.74%
2020-12-31	CN¥644.88 Million ≈ $94.37 Million	CN¥51.48 Million ≈ $7.53 Million	0.080x	+70.04%
2019-12-31	CN¥622.16 Million ≈ $91.04 Million	CN¥29.21 Million ≈ $4.27 Million	0.047x	+4059.95%
2018-12-31	CN¥579.72 Million ≈ $84.83 Million	CN¥654.24K ≈ $95.74K	0.001x	+100.74%
2017-12-31	CN¥583.33 Million ≈ $85.36 Million	CN¥-89.14 Million ≈ $-13.04 Million	-0.153x	-24.06%
2016-12-31	CN¥263.96 Million ≈ $38.63 Million	CN¥-32.51 Million ≈ $-4.76 Million	-0.123x	+58.14%
2015-12-31	CN¥205.79 Million ≈ $30.11 Million	CN¥-60.56 Million ≈ $-8.86 Million	-0.294x	-6.42%
2014-12-31	CN¥184.11 Million ≈ $26.94 Million	CN¥-50.91 Million ≈ $-7.45 Million	-0.277x	-1907.88%
2013-12-31	CN¥269.51 Million ≈ $39.44 Million	CN¥4.12 Million ≈ $603.20K	0.015x	-62.93%
2012-12-31	CN¥478.58 Million ≈ $70.03 Million	CN¥19.75 Million ≈ $2.89 Million	0.041x	-53.10%
2011-12-31	CN¥350.83 Million ≈ $51.34 Million	CN¥30.87 Million ≈ $4.52 Million	0.088x	-71.13%
2010-12-31	CN¥278.88 Million ≈ $40.81 Million	CN¥84.98 Million ≈ $12.43 Million	0.305x	+106.35%
2009-12-31	CN¥231.22 Million ≈ $33.84 Million	CN¥34.14 Million ≈ $5.00 Million	0.148x	+36.63%
2008-12-31	CN¥322.78 Million ≈ $47.23 Million	CN¥34.89 Million ≈ $5.10 Million	0.108x	-51.20%
2007-12-31	CN¥307.22 Million ≈ $44.96 Million	CN¥68.04 Million ≈ $9.96 Million	0.221x	+357.48%
2006-12-31	CN¥271.26 Million ≈ $39.69 Million	CN¥-23.33 Million ≈ $-3.41 Million	-0.086x	-141.28%
2005-12-31	CN¥268.54 Million ≈ $39.30 Million	CN¥55.96 Million ≈ $8.19 Million	0.208x	+15.06%
2004-12-31	CN¥267.57 Million ≈ $39.15 Million	CN¥48.46 Million ≈ $7.09 Million	0.181x	+292.13%
2003-12-31	CN¥259.16 Million ≈ $37.92 Million	CN¥-24.43 Million ≈ $-3.57 Million	-0.094x	-128.08%
2002-12-31	CN¥280.91 Million ≈ $41.11 Million	CN¥94.30 Million ≈ $13.80 Million	0.336x	+283.41%
2001-12-31	CN¥278.65 Million ≈ $40.78 Million	CN¥-51.00 Million ≈ $-7.46 Million	-0.183x	-944.87%
2000-12-31	CN¥380.02 Million ≈ $55.61 Million	CN¥8.23 Million ≈ $1.20 Million	0.022x	+172.82%
1999-12-31	CN¥347.80 Million ≈ $50.89 Million	CN¥-10.35 Million ≈ $-1.51 Million	-0.030x	-305.60%
1998-12-31	CN¥268.78 Million ≈ $39.33 Million	CN¥3.89 Million ≈ $569.06K	0.014x	--

About Tus Pharmaceutical Group Co Ltd

SHE:000590 China Drug Manufacturers - Specialty & Generic

Market Cap

$273.68 Million

CN¥1.87 Billion CNY

Market Cap Rank

#15013 Global

#4412 in China

Share Price

CN¥7.81

Change (1 day)

+0.26%

52-Week Range

CN¥7.71 - CN¥12.63

All Time High

CN¥26.17